Mr. Speaker, skyrocketing drug costs are threatening the future of medicare and putting an impossible burden on Canadians who need medically necessary drugs.
Liberal policies are to blame. Instead of a responsible program, what do we have, a complete flip-flop on Bill C-91 and 20-year patent protection for big brand name drug companies, a whitewash of last spring's review of Bill C-91, the elimination of the drug research bureau and now evidence that Industry Canada edited the Ernst & Young audit of research commitments made by PMAC.
Who is in charge? Why is the big brand name drug company running this country? Today, on behalf of seniors everywhere and Canadians who are concerned about the future of medicare, we call on this government to ensure need, not greed, is the basis of drug pricing policy in Canada.